IBDEI2DR ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,37986,2)
;;=^5010821
;;^UTILITY(U,$J,358.3,37987,0)
;;=M19.071^^146^1924^19
;;^UTILITY(U,$J,358.3,37987,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37987,1,3,0)
;;=3^Osteoarthritis,Right Ankle/Foot,Primary
;;^UTILITY(U,$J,358.3,37987,1,4,0)
;;=4^M19.071
;;^UTILITY(U,$J,358.3,37987,2)
;;=^5010820
;;^UTILITY(U,$J,358.3,37988,0)
;;=M19.90^^146^1924^20
;;^UTILITY(U,$J,358.3,37988,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37988,1,3,0)
;;=3^Osteoarthritis,Unspec Site
;;^UTILITY(U,$J,358.3,37988,1,4,0)
;;=4^M19.90
;;^UTILITY(U,$J,358.3,37988,2)
;;=^5010853
;;^UTILITY(U,$J,358.3,37989,0)
;;=M96.0^^146^1925^14
;;^UTILITY(U,$J,358.3,37989,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37989,1,3,0)
;;=3^Pseudarthrosis after fusion or arthrodesis
;;^UTILITY(U,$J,358.3,37989,1,4,0)
;;=4^M96.0
;;^UTILITY(U,$J,358.3,37989,2)
;;=^5015373
;;^UTILITY(U,$J,358.3,37990,0)
;;=R20.2^^146^1925^1
;;^UTILITY(U,$J,358.3,37990,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37990,1,3,0)
;;=3^Paresthesia of skin
;;^UTILITY(U,$J,358.3,37990,1,4,0)
;;=4^R20.2
;;^UTILITY(U,$J,358.3,37990,2)
;;=^5019280
;;^UTILITY(U,$J,358.3,37991,0)
;;=I87.003^^146^1925^12
;;^UTILITY(U,$J,358.3,37991,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37991,1,3,0)
;;=3^Postthrom syndr w/o compl of bilat lwr extrem
;;^UTILITY(U,$J,358.3,37991,1,4,0)
;;=4^I87.003
;;^UTILITY(U,$J,358.3,37991,2)
;;=^5008029
;;^UTILITY(U,$J,358.3,37992,0)
;;=I87.001^^146^1925^11
;;^UTILITY(U,$J,358.3,37992,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37992,1,3,0)
;;=3^Postrhomb syndr w/o compl of rt lwr extrem
;;^UTILITY(U,$J,358.3,37992,1,4,0)
;;=4^I87.001
;;^UTILITY(U,$J,358.3,37992,2)
;;=^5008027
;;^UTILITY(U,$J,358.3,37993,0)
;;=I80.01^^146^1925^8
;;^UTILITY(U,$J,358.3,37993,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37993,1,3,0)
;;=3^Phlebitis & Thromboph,Right Lower Sprfcl Vessels
;;^UTILITY(U,$J,358.3,37993,1,4,0)
;;=4^I80.01
;;^UTILITY(U,$J,358.3,37993,2)
;;=^5007821
;;^UTILITY(U,$J,358.3,37994,0)
;;=I80.02^^146^1925^6
;;^UTILITY(U,$J,358.3,37994,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37994,1,3,0)
;;=3^Phlebitis & Thromboph,Left Lower Sprfcl Vessels
;;^UTILITY(U,$J,358.3,37994,1,4,0)
;;=4^I80.02
;;^UTILITY(U,$J,358.3,37994,2)
;;=^5007822
;;^UTILITY(U,$J,358.3,37995,0)
;;=I80.03^^146^1925^4
;;^UTILITY(U,$J,358.3,37995,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37995,1,3,0)
;;=3^Phlebitis & Thromboph,Bilateral Lower Sprfcl Vessels
;;^UTILITY(U,$J,358.3,37995,1,4,0)
;;=4^I80.03
;;^UTILITY(U,$J,358.3,37995,2)
;;=^5007823
;;^UTILITY(U,$J,358.3,37996,0)
;;=I80.11^^146^1925^7
;;^UTILITY(U,$J,358.3,37996,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37996,1,3,0)
;;=3^Phlebitis & Thromboph,Right Femoral Vein
;;^UTILITY(U,$J,358.3,37996,1,4,0)
;;=4^I80.11
;;^UTILITY(U,$J,358.3,37996,2)
;;=^5007825
;;^UTILITY(U,$J,358.3,37997,0)
;;=I80.12^^146^1925^5
;;^UTILITY(U,$J,358.3,37997,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37997,1,3,0)
;;=3^Phlebitis & Thromboph,Left Femoral Vein
;;^UTILITY(U,$J,358.3,37997,1,4,0)
;;=4^I80.12
;;^UTILITY(U,$J,358.3,37997,2)
;;=^5007826
;;^UTILITY(U,$J,358.3,37998,0)
;;=I80.13^^146^1925^3
;;^UTILITY(U,$J,358.3,37998,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37998,1,3,0)
;;=3^Phlebitis & Thromboph,Bilateral Femora Vein
;;^UTILITY(U,$J,358.3,37998,1,4,0)
;;=4^I80.13
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2DR 3793 printed Apr 09, 2024@21:10:58 Page 2
IBDEI2DR ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,37986,2)
+2 ;;=^5010821
+3 ;;^UTILITY(U,$J,358.3,37987,0)
+4 ;;=M19.071^^146^1924^19
+5 ;;^UTILITY(U,$J,358.3,37987,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,37987,1,3,0)
+8 ;;=3^Osteoarthritis,Right Ankle/Foot,Primary
+9 ;;^UTILITY(U,$J,358.3,37987,1,4,0)
+10 ;;=4^M19.071
+11 ;;^UTILITY(U,$J,358.3,37987,2)
+12 ;;=^5010820
+13 ;;^UTILITY(U,$J,358.3,37988,0)
+14 ;;=M19.90^^146^1924^20
+15 ;;^UTILITY(U,$J,358.3,37988,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,37988,1,3,0)
+18 ;;=3^Osteoarthritis,Unspec Site
+19 ;;^UTILITY(U,$J,358.3,37988,1,4,0)
+20 ;;=4^M19.90
+21 ;;^UTILITY(U,$J,358.3,37988,2)
+22 ;;=^5010853
+23 ;;^UTILITY(U,$J,358.3,37989,0)
+24 ;;=M96.0^^146^1925^14
+25 ;;^UTILITY(U,$J,358.3,37989,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,37989,1,3,0)
+28 ;;=3^Pseudarthrosis after fusion or arthrodesis
+29 ;;^UTILITY(U,$J,358.3,37989,1,4,0)
+30 ;;=4^M96.0
+31 ;;^UTILITY(U,$J,358.3,37989,2)
+32 ;;=^5015373
+33 ;;^UTILITY(U,$J,358.3,37990,0)
+34 ;;=R20.2^^146^1925^1
+35 ;;^UTILITY(U,$J,358.3,37990,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,37990,1,3,0)
+38 ;;=3^Paresthesia of skin
+39 ;;^UTILITY(U,$J,358.3,37990,1,4,0)
+40 ;;=4^R20.2
+41 ;;^UTILITY(U,$J,358.3,37990,2)
+42 ;;=^5019280
+43 ;;^UTILITY(U,$J,358.3,37991,0)
+44 ;;=I87.003^^146^1925^12
+45 ;;^UTILITY(U,$J,358.3,37991,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,37991,1,3,0)
+48 ;;=3^Postthrom syndr w/o compl of bilat lwr extrem
+49 ;;^UTILITY(U,$J,358.3,37991,1,4,0)
+50 ;;=4^I87.003
+51 ;;^UTILITY(U,$J,358.3,37991,2)
+52 ;;=^5008029
+53 ;;^UTILITY(U,$J,358.3,37992,0)
+54 ;;=I87.001^^146^1925^11
+55 ;;^UTILITY(U,$J,358.3,37992,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,37992,1,3,0)
+58 ;;=3^Postrhomb syndr w/o compl of rt lwr extrem
+59 ;;^UTILITY(U,$J,358.3,37992,1,4,0)
+60 ;;=4^I87.001
+61 ;;^UTILITY(U,$J,358.3,37992,2)
+62 ;;=^5008027
+63 ;;^UTILITY(U,$J,358.3,37993,0)
+64 ;;=I80.01^^146^1925^8
+65 ;;^UTILITY(U,$J,358.3,37993,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,37993,1,3,0)
+68 ;;=3^Phlebitis & Thromboph,Right Lower Sprfcl Vessels
+69 ;;^UTILITY(U,$J,358.3,37993,1,4,0)
+70 ;;=4^I80.01
+71 ;;^UTILITY(U,$J,358.3,37993,2)
+72 ;;=^5007821
+73 ;;^UTILITY(U,$J,358.3,37994,0)
+74 ;;=I80.02^^146^1925^6
+75 ;;^UTILITY(U,$J,358.3,37994,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,37994,1,3,0)
+78 ;;=3^Phlebitis & Thromboph,Left Lower Sprfcl Vessels
+79 ;;^UTILITY(U,$J,358.3,37994,1,4,0)
+80 ;;=4^I80.02
+81 ;;^UTILITY(U,$J,358.3,37994,2)
+82 ;;=^5007822
+83 ;;^UTILITY(U,$J,358.3,37995,0)
+84 ;;=I80.03^^146^1925^4
+85 ;;^UTILITY(U,$J,358.3,37995,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,37995,1,3,0)
+88 ;;=3^Phlebitis & Thromboph,Bilateral Lower Sprfcl Vessels
+89 ;;^UTILITY(U,$J,358.3,37995,1,4,0)
+90 ;;=4^I80.03
+91 ;;^UTILITY(U,$J,358.3,37995,2)
+92 ;;=^5007823
+93 ;;^UTILITY(U,$J,358.3,37996,0)
+94 ;;=I80.11^^146^1925^7
+95 ;;^UTILITY(U,$J,358.3,37996,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,37996,1,3,0)
+98 ;;=3^Phlebitis & Thromboph,Right Femoral Vein
+99 ;;^UTILITY(U,$J,358.3,37996,1,4,0)
+100 ;;=4^I80.11
+101 ;;^UTILITY(U,$J,358.3,37996,2)
+102 ;;=^5007825
+103 ;;^UTILITY(U,$J,358.3,37997,0)
+104 ;;=I80.12^^146^1925^5
+105 ;;^UTILITY(U,$J,358.3,37997,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,37997,1,3,0)
+108 ;;=3^Phlebitis & Thromboph,Left Femoral Vein
+109 ;;^UTILITY(U,$J,358.3,37997,1,4,0)
+110 ;;=4^I80.12
+111 ;;^UTILITY(U,$J,358.3,37997,2)
+112 ;;=^5007826
+113 ;;^UTILITY(U,$J,358.3,37998,0)
+114 ;;=I80.13^^146^1925^3
+115 ;;^UTILITY(U,$J,358.3,37998,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,37998,1,3,0)
+118 ;;=3^Phlebitis & Thromboph,Bilateral Femora Vein
+119 ;;^UTILITY(U,$J,358.3,37998,1,4,0)
+120 ;;=4^I80.13
